Publications by authors named "Miroslav Zeman"

Claim this Profile
A
Associations of plasma phospholipid cis-vaccenic acid with insulin resistance markers in non-diabetic men with hyperlipidemia.
Jaroslav Macášek, Barbora Staňková, Aleš Žák, Markéta Růžičková, Radan Brůha, Miroslav Zeman

Nutr Diabetes· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome.
Aleš Žák, Marie Jáchymová, Michal Burda, Barbora Staňková, Miroslav Zeman

Metabolites· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Indices of Fatty Acid Elongases ELOVL6, ELOVL5, and ELOVL2 Activities in Patients with Impaired Fasting Glycemia.
Jaroslav Macášek, Miroslav Zeman, Aleš Žák, Barbora Staňková, Marek Vecka

Metab Syndr Relat Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk.
Marek Vecka, Aleš Žák, Eva Tvrzická, Magdalena Dušejovská, Barbora Staňková, Miroslav Zeman

Metab Syndr Relat Disord· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty Acid Composition of Plasma Phosphatidylcholine Determines Body Fat Parameters in Subjects with Metabolic Syndrome-Related Traits.
Miroslav Zeman, Marek Vecka, Michal Burda, Eva Tvrzická, Barbora Staňková

Metab Syndr Relat Disord· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Desaturases of fatty acids (FADS) and their physiological and clinical implication].
Aleš Žák, Adolf Slabý, Eva Tvrzická, Marie Jáchymová, Jaroslav Macášek, Miroslav Zeman

Cas Lek Cesk· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic effects of niacin: Current possibilities for its clinical use.
Miroslav Zeman, Marek Vecka, František Perlík, Barbora Staňková, Robert Hromádka

Acta Pharm· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile.
Milada Zemanova, Marek Vecka, Luboš Petruželka, Barbora Staňková, Aleš Žák, Miroslav Zeman

Med Sci Monit· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Jana Rychlíková, Marek Vecka, Marie Jáchymová, Jaroslav Macášek, Petr Hrabák, Miroslav Zeman

Cancer Biomark· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids.
Miroslav Zeman, Jaroslav Macášek, Michal Burda, Eva Tvrzická, Marek Vecka

Prostaglandins Leukot Essent Fatty Acids· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
Karel Dvorak, Radvan Hainer, Jaromir Petrtyl, Miroslav Zeman, Tomas Vareka

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
Miroslav Zeman, Marek Vecka, František Perlík, Róbert Hromádka, Barbora Staňková

Med Sci Monit· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study.
Milada Zemanová, Barbora Staňková, Zuzana Ušiakova, Eva Tvrzická, Alexandr Pazdro, Miroslav Zeman

Med Sci Monit· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xanthomas: clinical and pathophysiological relations.
Ales Zak, Miroslav Zeman, Adolf Slaby, Marek Vecka

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered activities of antioxidant enzymes in patients with metabolic syndrome.
Lucie Vávrová, Jana Kodydková, Miroslav Zeman, Magdaléna Dušejovská, Jaroslav Macášek

Obes Facts· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma fatty acid profile in depressive disorder resembles insulin resistance state.
Tomas Vareka, Marek Vecka, Roman Jirak, Eva Tvrzicka, Jaroslav Macasek, Miroslav Zeman

Neuro Endocrinol Lett· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.
Marek Vecka, Magdalena Dušejovská, Barbora Stankova, Miroslav Zeman, Lucie Vavrova

Neuro Endocrinol Lett· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical data.
Miroslav Zeman, Roman Jirak, Marek Vecka, Jiri Raboch, Ales Zak

Neuro Endocrinol Lett· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters.
Jaroslav Macášek, Marek Vecka, Aleš Žák, Miroslav Urbánek, Tomáš Krechler, Miroslav Zeman

Nutr Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Statin-ezetimibe combination in hyperlipidemia treatment].
Tomás Vareka, Daniela Vítková, Miroslav Zeman, Marek Vecka, Ales Zák

Cas Lek Cesk· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current status of pancreatic cancer diagnosis].
Tomás Krechler, Josef Horejs, Jan Ulrych, Miroslav Zeman, Jaroslav Macásek

Cas Lek Cesk· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reactive oxygen and nitrogen species in the clinical medicine].
Jaroslav Macásek, Miroslav Zeman, Marek Vecka, Lucie Vávrová, Jana Kodydková

Cas Lek Cesk· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Shy-Drager syndrome].
Magdaléna Dusejovská, Tomás Vareka, Jaroslav Macásek, Karel Hrubant, Ales Zák, Miroslav Zeman

Cas Lek Cesk· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Our experience with pancreatic cancer and its relation to diabetes mellitus].
Tomás Krechler, Miroslav Zeman, Marek Vecka, Marie Jáchymová, Josef Horejs

Cas Lek Cesk· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.
Miroslav Zeman, Roman Jirak, Marie Jachymova, Marek Vecka, Eva Tvrzicka

Neuro Endocrinol Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis